Sarepta shares plunge 40% as future of its gene therapy appears at risk - Echo Global News

Saturday, July 19, 2025

Sarepta shares plunge 40% as future of its gene therapy appears at risk



LivestreamMenuMake ItselectUSAINTLLivestreamSearch quotes, news & videosLivestreamWatchlistSIGN INMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenu

Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk.

The Food and Drug Administration will request that the company voluntarily stop all shipments of the treatment, Elevidys, a person familiar with the matter told CNBC.

No comments:

Post a Comment